Association of MTHFR, MTR, and MTRR polymorphisms with Parkinson's disease among ethnic Chinese in Taiwan

• Published in: Clinica chimica acta 2011-01, Vol.412 (3), p.332-338
• Main Authors: Fong, Chin-Shih, Shyu, Hann-Yeh, Shieh, Jia-Ching, Fu, Yi-Ping, Chin, Ting-Yu, Wang, Hsiao-Wei, Cheng, Chun-Wen
• Format: Article
• Language: English
• Subjects: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase - genetics; Aged; Aged, 80 and over; Asian Continental Ancestry Group - ethnology; Asian Continental Ancestry Group - genetics; Case-Control Studies; Female; Ferredoxin-NADP Reductase - genetics; Gene Frequency; Genetic polymorphism; Genetic Predisposition to Disease - genetics; Hospitals; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2) - genetics; Middle Aged; MTHFR; MTR; MTRR; Parkinson Disease - enzymology; Parkinson Disease - genetics; Parkinson's disease; Polymorphism, Genetic; Taiwan - ethnology
• ISSN: 0009-8981; 1873-3492
• DOI: 10.1016/j.cca.2010.11.004

Influence of folate/homocysteine conversion is considered to be important in the pathogenesis of Parkinson's disease (PD). However, association of the folate metabolic pathway gene polymorphisms with PD susceptibility remains unclear. To test this possibility in PD, we conducted a hospital-based case-control study constituting 211 patients and 218 age- and sex-matched controls of ethnic Chinese in Taiwan. Genotyping assay was performed to screen for polymorphisms of the methylenetetrahydrofolate reductase ( MTHFR C677T), methyltetrahydrofolate-homocysteine methyltransferase ( MTR A2756G), and 5-methyltetrahydrofolate-homocysteine methyltransferase reductase ( MTRR A1049G and C1783T) genes and assess the association between these genotype polymorphisms and PD risk using logistic regression analysis. Of these four non-synonymous polymorphisms, the MTRR 1049GG variant was significantly associated with PD susceptibility (OR = 3.17, 95%CI = 1.08–9.35). Furthermore, we stratified our patients based on the MTHFR 677TT genotype in different strata, a significant association between the joint effect of polymorphisms and PD risk was observed in those patients whose genotypes were MTRR A1049G/ MTR A2756G or MTRR C1783T/ MTR A2756G ( P < 0.05). Our findings provide support for the synergistic effects of polymorphisms in the folate metabolic pathway genes in PD susceptibility; the increased PD risk would be more significant in carriers with the polymorphisms of MTHFR, MTR, and MTRR genes.